Stocks-VERV-Verve Therapeutics Inc

VERV Verve Therapeutics Inc

14.24 -0.97 (-6.38%)
Delayed Prices By NASDAQ, in USD Market Open
Invest
Stocks-VERV-Verve Therapeutics Inc
VERV Verve Therapeutics Inc
Invest

FINANCIAL SUMMARY

For the quarter ended 31/12/2022, Verve Therapeutics Inc's revenues increased by 8.93% and amounted to 1.01M. Net income increased by 9.08% to -41.09M. Net assets increased by 0.55% to 550.93M and EPS increased from -0.79 to -0.67.
VERV's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
-245.75%
Net Profit Margin
-2,027.14%
Operating Margin
-8,536.17%
Return On Investment
-64.54%